Gene therapy is related to vaccines, although the products are mostly
intended for therapeutic use, and involves delivering DNA to the target cells
in the body, allowing them to produce molecules the lack of which are
implicated in genetic disorders, supplement immunity and many other potential
treatments.
Production of correctly coded
DNA (or RNA) strands for this purpose for use directly in patients, for
incorporation into vectors, or into recombinant cells used to produce proteins
that are the target product may be challenging, as the DNA molecules are large,
strongly charged and often start off in high particulate, viscous solutions.
No comments:
Post a Comment